Novel Wrist Sensor System to Promote Hemiparetic Arm Use in Home Daily Life of Chronic Stroke Survivors

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions
StrokeStroke SequelaeHemiparesis;Poststroke/CVA
Interventions
COMBINATION_PRODUCT

StrokeWear Motor and Behavioral Intervention

The intervention will consist of 1) the use of StrokeWear for goal directed movements (GDM) feedback and goal setting, 2) use of daily activity action planning (DAAP) to foster planned hemiparetic UE use during daily activities in the home and community, and 3) patient empowerment. Patient empowerment in this study will occur over 6-months as patients gain the ability to use the StrokeWear technology independently and develop skills to manage their GDM and DAAP.

OTHER

Usual Care

The intervention will consist in a sham version of the StrokeWear system and usual clinical care under the direction of a clinician. The sham version of the StrokeWear system will include sensing and recording technology to detect GDMs. However, study participants will not receive feedback from the system regarding the GDM counts.

Trial Locations (1)

02129

Spaulding Rehabilitation Hospital Boston, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BioSensics

INDUSTRY

collaborator

MGH Institute of Health Professions

OTHER

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Spaulding Rehabilitation Hospital

OTHER

NCT05626894 - Novel Wrist Sensor System to Promote Hemiparetic Arm Use in Home Daily Life of Chronic Stroke Survivors | Biotech Hunter | Biotech Hunter